Type I (Juvenile Onset) Diabetes Mellitus and Renal Failure

The Department of Medicine at UMDNJ-Robert Wood Johnson Medical School in New Brunswick is conducting a four-week study for patients, age 18 and older, with Type I diabetes mellitus and renal failure. The goal of the study is to evaluate the benefits of a new insulin for individuals who suffer from this condition. Monetary compensation is provided to those who qualify.

Stephen H. Schneider, MD, is the principal investigator. For additional information about the study, call Shelley Greenhaus, RN, at 732-235-7751.

Diabetes Mellitus with Kidney Complications

Diabetes specialists at UMDNJ-Robert Wood Johnson Medical School in New Brunswick are conducting a study of a new investigational drug to slow down the progression of kidney complications. To be eligible, participants must have Type I (age 18 to 65) or Type II (age 30 to 70) diabetes and have protein in the urine. Monetary compensation is available to those who complete the study.

Stephen H. Schneider, MD, is the principal investigator. For more information call Shelley Greenhaus, RN, at 732-235-7751.

Diabetes

The Department of Medicine at UMDNJ-Robert Wood Johnson Medical School in New Brunswick is looking for volunteers between the ages of 70 and 90 to participate in a diabetes study. To be eligible, volunteers must not now be taking medication to control their blood sugar. Participants will receive a physical exam, study tablets and relevant laboratory tests at no cost.

The principal investigator for the study is Avedis K. Khachadurian, MD. For more information call Shelley Greenhaus, RN, at 732-235-7751.

High Cholesterol

Volunteers with high blood cholesterol are being sought to participate in a study at UMDNJ-Robert Wood Johnson Medical School in New Brunswick. Participants must be between the ages of 21 and 70. The purpose of the investigational study is to evaluate the effectiveness of Zocor and Lipitor, drugs known to lower blood cholesterol and decrease the risk of heart disease. Those eligible will receive a physical exam, study medications and laboratory tests at no charge.

This study is under the direction of the principal investigator, Avedis K. Khachadurian, MD. Call Shelley Greenhaus, RN, at 732-235-7751 for more information.

Diabetes and High Cholesterol

UMDNJ-Robert Wood Johnson Medical School in New Brunswick is conducting a drug study to help lower cholesterol levels in individuals who suffer from diabetes and high cholesterol. Volunteers between the ages of 30 and 75, who take Actos or Avandia to control their diabetes, may be eligible to participate. Participants will receive a physical exam, study medications and relevant laboratory tests at no cost.

Stephen H. Schneider, MD, is the principal investigator. For more information call Shelley Greenhaus, RN, at 732-235-7751.

Atopic Dermatitis (Eczema)

UMDNJ-Robert Wood Johnson Medical School in New Brunswick is conducting a study on atopic dermatitis (eczema). To qualify, volunteers must be 6 years old or older and available for four weeks to 10 months (depending on the study). Participants will receive study medication, examinations and laboratory tests at no cost. .Some studies offer monetary compensation on completion.

The study is under the direction of the principal investigator Alice B. Gottlieb, MD, PhD. For more information, call Nancy Olesinski at 732-418-8484.

Psoriasis

The Clinical Research Center at UMDNJ-Robert Wood Johnson Medical School in New Brunswick is seeking volunteers with psoriasis to participate in research studies being conducted at the school. Eligible participants will receive physical examinations by board-certified dermatologists, laboratory tests and medication at no cost. Some programs have monetary compensation.

This study is under the direction of Alice B. Gottlieb, MD, PhD. For further details and to find out if you qualify, call Nancy Olesinski at 732-418-8484.

IV Antibiotic Research Study

Researchers at UMDNJ- Robert Wood Johnson Medical School in New Brunswick are looking for healthy volunteers to participate in an IV antibiotic research study. To qualify, participants must be between the ages of 18 and 55 with normal hearing tests. They must participate in four weeks of follow- up after completion of a single dose and five weeks of follow-up after completion of seven doses of the study drug. Volunteers must continue dose escalation and must not take over-the-counter, prescription or herbal supplements. Monetary compensation of $1,200 to $2,000 will be paid to those who complete the study.

Alice B. Gottlieb, MD, PhD, is the principal investigator for the study. For further information contact Nancy Olesinski at 732-418-8484.

Hypertension

Volunteers age 21 and older with high blood pressure are being sought to participate in a study to evaluate the effectiveness of dietary salt restriction on blood pressure variability. The study is being conducted at UMDNJ-Robert Wood Johnson Medical School in New Brunswick by the Section of Hypertension. Volunteers must have high blood pressure or be taking an antihypertensive medication. Participants who complete the study will receive monetary compensation.

The study is under the direction of the principal investigator Michael C. Ruddy, MD. For additional information call Mary Ann Mertz, RN, at 732-235-7825 (leave message, please).

Study Of A New Oral Contraceptive Pill

Women are needed to participate in a one year study of a new oral contraceptive pill at UMDNJ-Robert Wood Johnson Medical School in New Brunswick. To be eligible, volunteers must be in good health and between the ages of 18 and 35. They will receive a physical exam, a Pap test and study medication at no cost. Participants will be paid $450 upon completion of the study.

Gloria Bachmann, MD, Women’s Health Institute, is the principal investigator for the study. For more information call 732-235-7292 or 732-235-7353 Monday thru Friday from 9:30 AM to 4:30PM.

Implant/Denture Study

An implant study for denture stability is being conducted at UMDNJ-New Jersey Dental School. The study involves placing four dental implants in the lower jaw to stabilize an existing lower denture. Poor fitting dentures can affect eating, speaking and overall comfort. Since the study is subsidized by a research grant, there will be minimal cost to those who are eligible to participate.

Volunteers must be in good health, non-smokers and available for periodic check-ups over a two-year period.

The principal investigator for the study is Saul Weiner, DDS. For more information call Fran Devonshire, RN, at 973-972-4777.

Chronic Fatigue Syndrome

UMDNJ-New Jersey Medical School is currently conducting multiple studies to investigate the possible causes of medically unexplained fatigue and pain in disorders such as Chronic Fatigue Syndrome (CFS) and Fibromyalgia (FM). Patients who may have CFS or FM and healthy comparison subjects are needed to participate in the studies. Volunteers must be between the ages of 18 and 55. Medical evaluations and fitness tests are provided at no cost. Participants will be compensated for their time up to $200 per study. The NJ Chronic Fatigue Syndrome Cooperative Research Centers are located at the UMDNJ-Newark campus and at the VA Medical Center in East Orange.

Benjamin H. Natelson, MD, is the principal investigator for the studies. For more information call 800-248-8005 or visit the web page at www.umdnj/cfsweb/CFS.

The Study of Tamoxifen and Raloxifene to Prevent Breast Cancer

The Cooper Cancer Institute in Voorhees has been selected to participate in the National Surgical Adjuvant Breast and Bowel Project’s (NSABP) Study of Tamoxifen and Raloxifene (STAR). The study, sponsored by the National Cancer Institute (NCI), needs 22,000 women to participate nationwide. Volunteers must be postmenopausal women age 35 and older who are at increased risk for developing breast cancer. In STAR, the drugs tamoxifen and raloxifene will be compared for their effectiveness in reducing the occurrence of breast cancer in postmenopausal women. Participants will receive either tamoxifen or raloxifene for five years.

The principal investigator for the study is Generosa Grana, MD. For more information call the Cooper Cancer Institute at 856-325-6757.

Office Environment Study

Researchers at the Environmental and Occupational Health Sciences Institute (EOHSI) in Piscataway are seeking healthy female nonsmokers between the ages of 20 and 45 to participate in a three-year study to investigate the health effects of chemical mixtures found in office environments. The study, now in its second year, is funded by the National Institute of Occupational Health and Safety. Eligible participants will be exposed in controlled conditions to low-level chemical mixtures such as those found in some office buildings. They will be evaluated for physical symptoms, accuracy of performance on computer tasks and inflammation of the nose. Volunteers will receive a physical examination at no cost. Upon completion of three consecutive weekly sessions from 8:30 a.m. to 1:30 p.m., participants will receive $300.

EOHSI is a joint program of Rutgers and UMDNJ-Robert Wood Johnson Medical School. Nancy Fiedler, PhD, is the principal investigator for the study. For further information, including study participation requirements and eligibility, call 732-445-0123, extension 625.